Quantification of rimonabant (SR 141716A) in monkey plasma using HPLC with UV detection

Journal of Chromatographic Science

Volumn 48, Issue 6, 2010, Pages 491-495

  Javors, Martin A ^a   Sanchez, Jesus J ^a   McMahon, Lance R ^a  

^a University of Texas Health Science Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACACA MULATTA;

EID: 77955483121     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/48.6.491     Document Type: Article

References (11)

1. M. Rinaldi-Carmona, F. Barth, M. Heaulme, D. Shire, B. Calandra, C. Congy, S. Martinez, J. Maruani, G. Neliat, D. Caput et al. SR 141716A, a potent and selective antagonist of the brain cannabi-noid receptor. FEBS Lett. 350:240-244 (1994).
2. M. Rinaldi-Carmona, F. Barth, M. Heaulme, R. Alonso, D. Shire, C. Congy, P. Soubrie, J. C. Breliere, and G. Le Fur. Biochemical and pharmacological characterization of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci. 56:1941-1947 (1995).
3. P. M. Beardsley and B. F. Thomas. Current evidence supporting a role of cannabinoid CB1 receptor antagonists as potential pharma-cotherapies for drug abuse disorders. Behavior. Pharmacol. 16:275-296 (2005).
4. G. Tanda, P. Munzar, and S. R. Goldberg. Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nature Neurosci. 3:1073-1074 (2000).
5. 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide. Psychopharmacol. 156:369-380 (2001).
6. L. R. McMahon. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR141716A in rhesus monkeys pretreated with δ9- tetrahydrocannabinol. Psychopharmacol. 188:306-314 (2006).
7. M. A. Huestis, D. A. Forelick, S. J. Heishman, K. L. Preston, R. A. Nelson, E. T. Moolchan, and R. A. Frank. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716A. Arch. Gen. Psych. 58:322-328 (2001).
8. Q. Zhang, P. Ma, W. Wang, R. B. Cole, and G. Wang. In vitro metabolism of diarylpyrazoles, a novel group of cannabinoid receptor ligands. Drug Metab. Dispos. 33:508-517 (2005).
9. Y. Hsieh, C. J. G. Duncan, and J.-M. Brisson. Fused-core silica column high-performance liquid chromatography/tandem mass spectrometric determination of rimonabant in mouse plasma. Anal. Chem. 79:5668-5673 (2007). (Pubitemid 47229813)
10. M. McCulloch, X. Zhou, Y. Xu, S. Brunell, and L. Spear. Determination of endocannabinoid receptor antagonist SR141716 (rimonabant) in plasma by liquid chromatograph tandem mass spectrometry. J. Chromatogr. B 863:258-265 (2008).
11. L. R. McMahon, M. A. Javors, and C. P. France. Changes in relative potency among positive GABAA receptor modulators upon discontinuation of chronic benzodiazepine treatment in rhesus monkeys. Psychopharmacol. 192:135-145 (2007).